Table 1.
Social epidemiology | Psychopharmacology | Sociopharmacology | |
---|---|---|---|
Level of analysis | Focus at the sociocontextual and system level | Focus at the individual level | Focus on interactions across sociocontextual and individual levels |
Assumes determinants of tobacco use differ across populations | Assumes determinants of tobacco use are common across populations | Assumes a common set of determinants of tobacco use that differ in strength or relevance across populationsIdentifies proximal factors that channel distal influences on tobacco use behavior | |
Identifies distal influences on tobacco use behavior | Identifies proximal influences on tobacco use behavior | ||
Example theoretical constructs | Discrimination | Drug reward | Discrimination serving as a conditioned cue triggering tobacco use |
Cultural acceptance of smoking | Drug-induced reward enhancement | Nicotine-induced distraction away from attending to cues reflecting neighborhood disorder | |
Targeted marketing of tobacco products to disparity groups | Negative reinforcement | Nicotine-induced enhancement of the reward value of reinforcers in socioeconomically-deprived environmentsGreater value placed on the arousal-enhancing effects of nicotine for blue-collar workers whose jobs require high levels of arousal | |
Physical environment (eg, density of tobacco retailers in communities with high prevalence of people from TRHD groups) | Withdrawal | ||
Reduced access to health care | Behavioral economic value | ||
Biases in the legal system | Drug-induced changes in cognitive performance | ||
Neighborhood deprivation and crime | Conditioning of drug-related and other cues | ||
Social class | Alternative reinforcers | ||
Clustering of biological vulnerability | Pharmacodynamic and pharmacokinetic processes underlying drug effects | ||
Methodology | Naturalistic, correlational, or descriptive designs | Experimental designs | Quasi- or fully-experimental designs crossing a sociodemographic TRHD variable or social determinant of TRHD with a psychopharmacological manipulation |
Large community samples | Smaller samples | Correlational designs examining the relation between a social determinant of TRHD and a psychopharmacological cause or consequence of tobacco use | |
Data often collected in the field | Data often collected in the laboratory | Value on both internal and external validity | |
High value on generalizability and ecological validity | High value on internal validity and isolating narrow mechanisms | ||
Evidence for causal effects is modest | Evidence for causal effects is strong | ||
Statistical control emphasized | Experimental control emphasized | ||
Basic methodology: studying naturalistic associations of sociodemographic variables or social constructs to tobacco use variables | Basic methodology: studying the effects of experimentally-manipulated tobacco administration or deprivation on variables indicative of addiction liability | ||
Intervention | Target policy and system-level change | Pharmacotherapy | Combination of pharmacotherapy and/or behavioral interventions that offset sociocontextual and psychopharmacological determinants of tobacco use |
Individual-level interventions are adapted for use in specific populations | Interventions are not generally adapted for use for specific populations | Targeting psychopharmacological mechanisms linking sociocontextual factors and tobacco use when social factors are immutable | |
Behavioral interventions incorporate sociological constructs (eg, culturally-adapted counseling) | Behavioral interventions that target psychopharmacological processes (eg, contingency management to reinforce abstinence) | Personalized medicine tailored to population based on biological/social factors (eg, polygenetic risk score, sociodemographic risk assessment) | |
Risk propensity assessment |
TRHD = tobacco-related health disparities.